» Articles » PMID: 30348049

Bifrontal Active and Sham RTMS in Treatment-resistant Unipolar Major Depression

Overview
Publisher Informa Healthcare
Specialties Pharmacology
Psychiatry
Date 2018 Oct 24
PMID 30348049
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Prevention of the recurrence of major depression and its residual symptoms requires effective treatment. Our aim was to study the effects of bifrontal active rTMS controlled by sham rTMS in treatment-resistant unipolar major depressive disorder (MDD).

Methods: Thirty-seven patients with treatment-resistant MDD were randomized into two groups. One group received a total of 30 sessions of active bifrontal rTMS (10 Hz rTMS on left dorsolateral prefrontal cortex (DLPFC) and 1 Hz rTMS on right DLPFC) and the other group received bilateral sham rTMS on five days a week for six weeks.

Results: Depressive symptoms significantly improved in both the groups, but without a significant group difference. Furthermore, patients with psychotic depression improved similarly to those with moderate or severe depression.

Conclusions: The results of present study indicate a large sham effect of stimulation treatment. The intensive structured treatment protocol may explain the positive outcome in both the groups. It is important to recognize, appreciate, and utilize placebo effects as a significant means of rehabilitation in psychiatric care.

Citing Articles

Systematic Review and Meta-Analysis of the Placebo Effect and its Correlates in Obsessive Compulsive Disorder.

Mohamadi S, Ahmadzad-Asl M, Nejadghaderi S, Jabbarinejad R, Mirbehbahani S, Sinyor M Can J Psychiatry. 2022; 68(7):479-494.

PMID: 35876317 PMC: 10408559. DOI: 10.1177/07067437221115029.


Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2021; 21(4):1-232.

PMID: 34055112 PMC: 8129638.


The Effects of Repetitive Transcranial Magnetic Stimulation on Anxiety in Patients With Moderate to Severe Traumatic Brain Injury: A Analysis of a Randomized Clinical Trial.

Rodrigues P, Zaninotto A, Ventresca H, Neville I, Hayashi C, Brunoni A Front Neurol. 2020; 11:564940.

PMID: 33343483 PMC: 7746857. DOI: 10.3389/fneur.2020.564940.